We observed that CISD2 was significantly related to most of the markers of Th1, Th2, and Treg cells in LGG, while it was related to rare markers of these cells in GBM, indicating that CISD2 dynamically modulates T lymphocyte immunity with glioma progression. Here, CISD2 is linked to central nervous system cancer.